TNF Pharmaceuticals, Inc. (TNFA) Stock Overview
Explore TNF Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
TNF Pharmaceuticals, Inc. (TNFA)
Key Financials
Key Financials
Market Cap
9.2M
P/E Ratio
-0.24
EPS (TTM)
$-202.00
ROE
-0.58%
TNFA Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of TNF Pharmaceuticals, Inc. (NASDAQ: TNFA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, TNF Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of TNFA on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $1.54 for the NASDAQ listing.
Key metrics behind TNF Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.24 and a market capitalization of 9.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of TNFA on the NASDAQ.